AnaptysBio, Inc.
AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
Mentions
2 mentions · latest on 3 Sept 2026
| The Acquirers PodcastPodcast | Patience Is the Ultimate Edge in Investing | Matt Sweeney | Listen · 54:45 | 3 Sept 2026 |
| The No Pile | - | 22 Aug 2026 |